Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma, IDH-Wildtype

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cedars-Sinai Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.trial.info@cshs.org · 310-423-2133
    Contact: Principal Investigator (Jeremy D. Rudnick)
  • Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 904-202-7468
    Contact: Principal Investigator (Robert Cavaliere)
  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@moffitt.org · 800-679-0775
    Contact: Principal Investigator (Joaquim Farinhas)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Michelle M. Kim)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Ashley L. Sumrall)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Annick Desjardins)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Marc Benayoun)
  • Rhode Island Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · 401-444-1488
    Contact: Principal Investigator (Eric T. Wong)
  • Edwards Comprehensive Cancer Center, Huntington, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · Christina.Cole@chhi.org · 304-399-6566
    Contact: Principal Investigator (Toni O. Pacioles)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Sonikpreet Aulakh)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Michael Veronesi)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Michael Veronesi)
Study leads
  • Daniel P Barboriak

    Principal Investigator

    ECOG-ACRIN Cancer Research Group